Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IGC | Common Stock | Options Exercise | $0 | +100K | +18.87% | $0.00 | 630K | Mar 21, 2022 | Direct | F1 |
transaction | IGC | Common Stock | Options Exercise | $0 | +93.8K | +14.88% | $0.00 | 724K | May 31, 2022 | Direct | F2 |
transaction | IGC | Common Stock | Options Exercise | $0 | +31.3K | +4.32% | $0.00 | 755K | Jun 1, 2022 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IGC | Restricted Stock Units | Options Exercise | $0 | -100K | -12.5% | $0.00 | 700K | Mar 21, 2022 | Common Stock | 100K | $0.00 | Direct | F1 |
transaction | IGC | Restricted Stock Units | Options Exercise | $0 | -93.8K | -13.39% | $0.00 | 606K | May 31, 2022 | Common Stock | 93.8K | $0.00 | Direct | F2 |
transaction | IGC | Restricted Stock Units | Options Exercise | $0 | -31.3K | -5.15% | $0.00 | 575K | Jun 1, 2022 | Common Stock | 31.3K | $0.00 | Direct | F2 |
Id | Content |
---|---|
F1 | On July 19, 2021, the Reporting Person was granted RSUs subject to vesting equally over three years starting on March 31, 2022. |
F2 | On December 20, 2021, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved. On May 31 and June 1, 2022, two of the milestones related to our IGC-AD1 clinical trials were reached. |